• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENCORE MEDICAL L.P. FMP HIP; LINER, ACETABULAR, FMP CONSTRAINED 28XMP8

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENCORE MEDICAL L.P. FMP HIP; LINER, ACETABULAR, FMP CONSTRAINED 28XMP8 Back to Search Results
Model Number 436-28-000
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 03/01/2019
Type of Reportable Event Serious Injury
Event or Problem Description
Third revision surgery - due to an unknown reason.
 
Additional Manufacturer Narrative
Manufacturer narrative: the reason for this revision surgery was due to unknown reasons.The previous revision surgery and the revision surgery detailed in this investigation occurred 3.3 months apart.The in vivo time for the reported component is 1.8 years, from a more previous revision surgery.There is no information in this complaint about any patient injuries, activities, or accidents that may have contributed to the need for this revision surgery.There are no reported pre-existing patient health conditions.The healthcare professional indicated there was no delay in surgery and another suitable device was available for use.The revision surgery was completed as intended.The device was disposed of at the hospital and not made available to djo surgical for examination.A review of the implant device history records (dhr), shows that the reported component used in the previous surgery, when released for use, met design and manufacturing requirements.There were no non-conforming material reports (ncmrs) associated with the product that may have contributed to the reported event.The device was verified to have gone through an acceptable sterilization process and was within its expiration date at the time of use during the previous surgery.Customer complaint history of the reported device showed no present trends or on-going issues that are in need of review.The root cause of this complaint was a revision surgery due to unknown reasons.There were no findings during this investigation that indicate that the reported device was defective.There are multiple factors that may contribute to an event that are outside of the control of djo surgical.Inventory containment is not required as there are no indications of a product or process issue affecting implant safety or effectiveness.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FMP HIP
Common Device Name
LINER, ACETABULAR, FMP CONSTRAINED 28XMP8
Manufacturer (Section D)
ENCORE MEDICAL L.P.
9800 metric blvd
austin TX 78758 5445
MDR Report Key8465642
Report Number1644408-2019-00237
Device Sequence Number16191205
Product Code KWZ
UDI-Device Identifier00888912085663
UDI-Public(01)00888912085663
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
K023794
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Device Explanted Year2019
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 04/09/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date08/26/2021
Device Model Number436-28-000
Device Catalogue Number436-28-008
Device Lot Number500C1009
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 03/01/2019
Supplement Date Received by Manufacturer04/03/2019
Initial Report FDA Received Date03/29/2019
Supplement Report FDA Received Date04/09/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
436-28-000, LOT 496C1073; 436-28-008, LOT 500C1009; 436-28-008, LOT 500C1009
Outcome Attributed to Adverse Event Required Intervention;
Patient Age41 YR
-
-